Back

Association between sex and efficacy of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency: an AFFIRM-AHF subgroup analysis

28 August 2023 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Medical therapy for acute heart failure and changing outcomes Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Giuseppe Rosano

St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Impact of in-hospital initiation of sodium-glucose cotransporter-2 inhibitors in patients with heart failure and reduced ejection fraction
Ms M. Diez (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Evidence-based heart failure therapies at discharge of patients with acute coronary syndromes and reduced ejection fraction: Data from the ACSIS survey
Doctor F. Bahouth (Nazareth, IL)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors and vericiguat in real-world patients admitted for worsening heart failure
Doctor R. Tarantini (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry.
Professor P. Maury (Toulouse, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Medical therapy for acute heart failure and changing outcomes

The Event

Event poster

ESC Congress 2023

28 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources